Transcripts Lyell Immunopharma, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 18/06/2026			Varia. 5j.	Varia. 1 janv.
12,74 ^USD	+1,76 %		-5,63 %	-58,61 %

12/06	Lyell Immunopharma présente des données de sécurité actualisées et des analyses translationnelles pour le rondecabtagene autoleucel chez les patients atteints de lymphome à grandes cellules B	CI
10/06	Transcript : Lyell Immunopharma, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 11:20 AM

10/06	Transcript : Lyell Immunopharma, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 11:20 AM
23/05	Transcript : Lyell Immunopharma, Inc. Presents at Stifel 2026 Targeted Oncology Virtual Forum, May-20-2026 04:00 PM
23/05	Transcript : Lyell Immunopharma, Inc. Presents at H.C. Wainwright 4th Annual BioConnect Investor Conference, May-19-2026 11:00 AM
17/04	Transcript : Lyell Immunopharma, Inc. Presents at 25th Annual Needham Virtual Healthcare Conference, Apr-14-2026 11:00 AM
19/03	Transcript : Lyell Immunopharma, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-09-2026 10:00 AM
18/03	Transcript : Lyell Immunopharma, Inc. Presents at The Citizens Life Sciences Conference 2026, Mar-10-2026 11:55 AM
06/03	Transcript : Lyell Immunopharma, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 09:10 AM
15/01/25	Transcript : Lyell Immunopharma, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 09:00 AM